Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Figure out How to Plan for Your Web-based Degree monetarily- Don’t let food poisoning crash your Thanksgiving dinner
- NASA begins fueling rocket to launch astronauts on the first lunar trip in half a century
- Nordic people know how to beat the winter blues. Here's how to find light in the darkest months
- What are parents to do as doctors clash with Trump administration over vaccines?
- Pilot captures jaw-dropping northern lights show from 36,000 feet (photos)
- SpaceX launches Starlink satellites from California on 160th Falcon 9 flight of the year (video)
- This Week In Space podcast: Episode 192 — Space, 2026!
- Far-right AfD invited back to Munich Security Conference in 2026
